Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

The National Institutes of Health (NIH) is seeking research proposals to advance translational research on schizophrenia and related disorders in mid to late life. The purpose of this initiative is to better understand the emergence and trajectory of these disorders and to identify targets for future development of prevention and treatment efforts. • The research should focus on the mechanisms underlying the generation and trajectory of schizophrenia and related disorders in mid to late life. • The initiative aims to identify targets for future development of prevention and treatment efforts. • Eligible applicants include various organizations, such as nonprofits, institutions of higher education, and small businesses. • The application deadline is September 7, 2026.